CareFusion Acquires GE Healthcare’s Clinical Consumables Division
This article was originally published in The Gray Sheet
Executive Summary
Following its acquisition of GE Healthcare’s Vital Signs unit for $500 million, CareFusion will become the second largest player in the more than $3 billion global respiratory and anesthesia consumables market.
You may also be interested in...
Device/Diagnostics Quarterly Deal Statistics, Q4 2013
Device companies finished 2013 strong, raising $1.2 billion in Q4, the highest quarter total of the year. CVS Caremark’s $2.1 billion buy of Apria’s infusion therapy business was the largest M&A of the year, and late-stage venture rounds dominated the $423 million total in diagnostics funding.
GE Gains Sleep Apnea, Anesthesia Products In $860 Mil. Vital Signs Purchase
GE Healthcare's $860 million acquisition of Vital Signs Inc. provides an entry into the rapidly growing sleep apnea market and complementary offerings for its anesthesia and broader respiratory care businesses
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.